Skip to main content
Clinical Trials/NCT04461860
NCT04461860
Unknown
N/A

Assessment of Pain of Pelvic Congestion Syndrome Treated by Coils Embolization (SCVPC)

University Hospital, Brest1 site in 1 country20 target enrollmentApril 21, 2020
ConditionsPelvic Pain

Overview

Phase
N/A
Intervention
Not specified
Conditions
Pelvic Pain
Sponsor
University Hospital, Brest
Enrollment
20
Locations
1
Primary Endpoint
Pelvic congestion pain relief
Last Updated
5 years ago

Overview

Brief Summary

Summary:

Main Objective: to evaluate the efficacy of pelvic gonadal vein embolization with coils in treatment of pelvic congestion syndrome Methods: retrospective study included 25 patients in the University hospital of Brest.

The Primary Outcome Measure: To evaluate (to measure) pain relief using visual analogous scale (VAS) before and after gonadal vein embolization for pelvic congestion syndrome The Secondary Outcome Measures were to assess the impact of the treatment on specific and general symptoms through a survey.

Detailed Description

A retrospective, non-invasive monocentric study of our Hospital 10-year registry (including data on MRI angiography and Vascular Doppler Ultrasound) of patients who have already undergone coil embolization of pelvic gonadal vein in treatment of pelvic congestion syndrome. These patients will be contacted by phone to participate in the study. An information letter will be handed out and the study protocol will be explained to the patients. After obtaining their written consent, they will be asked to fill out the study's validated questionnaire at home and return it to us through pre-paid regular mail. A face to face interview with the patient will be scheduled to assess the correlation between patient's clinical symptoms and survey results. There will be no change in patient's routine follow-up care. All physician investigators of the study are experts in their field of medicine (e.g. interventional MRI angiography, vascular disease).

Registry
clinicaltrials.gov
Start Date
April 21, 2020
End Date
May 2021
Last Updated
5 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Clinical symptoms of pelvic congestion syndrome documented by Vascular Doppler ultrasound and vascular dynamic MRI
  • Failed medical treatment.
  • \> 18 years \< 60 years old

Exclusion Criteria

  • \< 18 years old
  • Under legal guardian
  • Asymptomatic pelvic congestion syndrome
  • Psychiatric disorder
  • Endometriosis.
  • Chronic pelvic disease
  • Pregnancy
  • Neoplasia
  • Acute intermittent porphyria

Outcomes

Primary Outcomes

Pelvic congestion pain relief

Time Frame: pre-embolization and 1 month post-gonadal vein embolization

To evaluate (to measure) pain relief using visual analogous scale before and after gonadal vein embolization for pelvic congestion syndrome. A high score means a worse outcome.

Secondary Outcomes

  • evaluation of specific pelvic syndrome symptoms using a self-reported questionnaire survey(pre-embolization and 1 month post-gonadal vein embolization)
  • evaluation of general pelvic syndrome symptoms using a self-reported questionnaire survey(pre-embolization and 1 month post-gonadal vein embolization)

Study Sites (1)

Loading locations...

Similar Trials